Home › Carcinoma in Situ › New York
Carcinoma in Situ clinical trials in New York
4 studies for Carcinoma in Situ are looking for participants at sites in New York.
Cities in New York
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06833073Project: Every Child for Younger Patients With Cancer
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- Roswell Park Cancer Institute, Buffalo
- and 12 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.